WHO ICTRP trial
An open, controlled clinical trial for evaluation of ganovo combined with…
ChiCTR2000030000 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000030000 |
|---|---|
| Public title | An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19) |
| Scientific title | An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19) |
| Primary sponsor | Nanchang Ninth Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Pneumonia caused by new coronavirus |
| Interventions | Ganovo / ritonavir group:Ganovo/ ritonavir oral;Pegasys group:Pegasys injection;Novaferon group:Novaferon intramuscular injection+Spray inhalation;Coriolus group:Coriolus oral;Comparator:TCM+Spray inhalation |
| Registration date | Feb 19, 2020 |
| Target size | Ganovo / ritonavir group:10;Pegasys group:10;Novaferon group:10;Coriolus… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: